GFAP and Alzheimer disease: Recently, plasma GFAP levels have been associated with increased Aβ pathology (Benedet et al., 2021; Pereira et al., 2021) and are elevated in older individuals at risk of AD (Chatterjee et al., 2021) further highlighting the relevance of astrocytes in the disease.